Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation

Journal of Cellular Physiology

Volumn 217, Issue 3, 2008, Pages 769-777

  Miyazaki, Tatsuya ^a   Miyauchi, Satoshi ^b   Tawada, Akira ^c   Anada, Takahisa ^a   Matsuzaka, Satoshi ^a   Suzuki, Osamu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b PG Research   (Japan)

^c HYDROX Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIGLYCAN; BONE MORPHOGENETIC PROTEIN 4; CHONDROITIN SULFATE; CHONDROITIN SULFATE E; FLUORESCEIN; GLYCOSAMINOGLYCAN; N ACETYLGALACTOSAMINE 4 SULFATASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL GROWTH; COLLAGEN METABOLISM; CONTROLLED STUDY; FLUORESCENCE CORRELATION SPECTROSCOPY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SULFATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CATTLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHONDROITIN SULFATES; CHONDROITINASES AND CHONDROITIN LYASES; COLLAGEN; DISACCHARIDES; HUMANS; MICE; OSTEOBLASTS; SPECTROMETRY, FLUORESCENCE; SWINE;

EID: 54049091585     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21557     Document Type: Article

References (57)

1. Ameye L, Young MF. 2002. Mice deficient in small leucine-rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R-116R.
2. Beck GR Jr, Zerler B, Moran E. 2001. Gene array analysis of osteoblast differentiation. Cell Growth Differ 12:61-83.
3. Bellows CG, Aubin JE. 1989. Determination of numbers of osteoprogenitors present in islated fetal rat calvaria cells in vitro. Dev Biol 133:8-13.
4. Bergefall K, Trybala E, Johansson M, Uyama T, Naito S, Yamada S, Kitagawa H, Sugahara K, Bergstrom T. 2005. Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J Biol Chem 280:32193-32199.
5. Berland KM. 2004. Fluorescence correlating spectroscopy: A new tool for quantification of molecular interactions. Methods Mol Biol 261:383-398.
6. Bhandari M, Hirsh J, Weitz JI, Young E, Venner TJ, Shaughnessy SG. 1998. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 80:413-417.
7. Bierbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees TK, Funk RH, Worch H. 2006. Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: Characterization and influence on osteoblastic cells. J Biomed Mater Res A 77:551-562.
8. Boskey AL, Spevak L, Doty SB, Rosenberg L. 1997. Effects of bone CS-proteoglycans, DS-decorin, and DS-biglycan on hydroxyapatite formation in a gelatin gel. Calcif Tissue Int 61:298-305.
9. Bouvier M, Couble ML, Hartmann DJ, Gauthier JP, Magloire H. 1990. Ultrastructural and immunocytochemical study of bone-derived cells cultured in three-dimensional matrices: Influence of chondroitin-4 sulfate on mineralization. Differentiation 45:128-137.
10. Chen XD, Fisher LW, Robey PG, Young MF. 2004. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J 18:948-958.
11. Clement AM, Nadanaka S, Masayama K, Mandl C, Sugahara K, Faissner A. 1998. The DSD-1 carbohydrate epitope depends on sulfation, correlates with chondroitin sulfate D motifs, and is sufficient to promote neurite outgrowth. J Biol Chem 273:28444-28453.
12. Deepa SS, Kalayanamitra K, Ito Y, Kongtawelert P, Fukui S, Yamada S,Mikami T, Sugahara K. 2007. Novel sulfated octa- and decasaccharides from squid cartilage chondroitin sulfate E: Sequencing and application for determination of the epitope structure of the monoclonal antibody MO-225. Biochemistry 46:2453-2465.
13. Deepa SS, Umehara Y, Higashiyama S, Itoh N, Sugahara K. 2002. Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. J Biol Chem 277:43707-43716.
14. Eliakim R, Gilead L, Ligumsky M, Okon E, Rachmilewitz D, Razin E. 1986. Histamine and chondroitin sulfate E proteoglycan released by cultured human colonic mucosa: Indication for possible presence of E mast cells. Proc Natl Acad Sci USA 83:461-464.
15. Gospodarowicz D, Cheng J, Lui GM, Baird A, Bohlent P. 1984. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: Identity with pituitary fibroblast growth factor. Proc Natl Acad Sci USA 81:6963-6967.
16. Handschin AE, Trentz OA, Hoerstrup SP, Kock HJ, Wanner GA, Trentz O. 2005. Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro. Br J Surg 92:177-183.
17. Hausser HJ, Brenner RE. 2004. Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro. J Cell Biochem 91:1062-1073.
18. Hikino M, Mikami T, Faissner A, Vilela-Silva AC, Pavao MS, Sugahara K. 2003. Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: Implications of dermatan sulfate in neuritogenesis in the brain. J Biol Chem 278:43744-43754.
19. Hoshi K, Ejiri S, Ozawa H. 2001. Localizational alterations of calcium, phosphorus, and calcification-related organics such as proteoglycans and alkaline phosphatase during bone calcification. J Bone Miner Res 16:289-298.
20. Hurley MM, Kessler M, Gronowicz G, Raisz LG. 1992. The interaction of heparin and basic fibroblast growth factor on collagen synthesis in 21-day fetal rat calvariae. Endocrinology 130:2675-2682.
21. Iozzo RV, Murdoch AD. 1996. Proteoglycans of the extracellular environment: Clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 10:598-614.
22. Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nurcombe V, Cool SM. 2007. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol 210:38-50.
23. Jasuja R, Allen BL, Pappano WN, Rapraeger AC, Greenspan DS. 2004. Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin. J Biol Chem 279:51289-51297.
24. Jiang H, Liu XY, Zhang G, Li Y. 2005. Kinetics and template nucleation of self-assembled hydroxyapatite nanocrystallites by chondroitin sulfate. J Biol Chem 280:42061-42066.
25. Jiao X, Billings PC, O'Connell MP, Kaplan FS, Shore EM, Glaser DL. 2007. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem 282:1080-1086.
26. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. 1988. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174:168-176.
27. Kram V, Zcharia E, Yacoby-Zeevi O, Metzger S, Chajek-Shaul T, Gabet Y, Muller R, Vlodavsky I, Bab I. 2006. Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol 207:784-792.
28. Kvist AJ, Johnson AE, Morgelin M, Gustafsson E, Bengtsson E, Lindblom K, Aszodi A, Fassler R, Sasaki T, Timpl R, Aspberg A. 2006. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem 281:33127-33139.
29. Martinovic S, Borovecki F, Miljavac V, Kisic V, Maticic D, Francetic I, Vukicevic S. 2006. Requirement of a bone morphogenetic protein for the maintenance and stimulation of osteoblast differentiation. Arch Histol Cytol 69:23-36.
30. Mochida Y, Parisuthiman D, Yamauchi M. 2006. Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. Adv Exp Med Biol 585:101-113.
31. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M. 2003. Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun 305:6-9.
32. Nikitovic D, Zafiropoulos A, Tzanakakis GN, Karamanos NK, Tsatsakis AM. 2005. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 25:2851-2856.
33. Ohta H, Wakitani S, Tensho K, Horiuchi H, Wakabayashi S, Saito N, Nakamura Y, Nozaki K, Imai Y, Takaoka K. 2005. The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2. J Bone Miner Metab 23:420-425.
34. Paralkar VM, Hammonds RG, Reddi AH. 1991. Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade. Proc Natl Acad Sci USA 88:3397-3401.
35. Parisuthiman D, Mochida Y, Duarte WR, Yamauchi M. 2005. Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res 20:1878-1886.
36. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL. 2000. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407:1029-1034.
37. Powell AK, Fernig DG, Turnbull JE. 2002. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex. J Biol Chem 277:28554-28563.
38. Qin C, Huang B, Wygant JN, McIntyre BW, McDonald CH, Cook RG, Butler WT. 2006. A chondroitin sulfate chain attached to the bone dentin matrix protein 1 NH2-terminal fragment. J Biol Chem 281:8034-8040.
39. Ruppert R, Hoffmann E, Sebald W. 1996. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237:295-302.
40. Sakamoto S, Sakamoto M, Goldberg L, Colarusso L, Gotoh Y. 1989. Mineralization induced by beta-glycerophosphate in cultures leads to a marked increase in collagenase synthesis by mouse osteogenic MC3T3-E1 cells under subsequent stimulation with heparin. Biochem Biophys Res Commun 162:773-780.
41. Seldin DC, Seno N, Austen KF, Stevens RL. 1984. Analysis of polysulfated chondroitin disaccharides by high-performance liquid chromatography. Anal Biochem 141:291-300.
42. Silverman L, Boskey AL. 2004. Diffusion systems for evaluation of biomineralization. Calcif Tissue Int 75:494-501.
43. Sotogaku N, Tully SE, Gama CI, Higashi H, Tanaka M, Hsieh-Wilson LC, Nishi A. 2007. Activation of phospholipase C pathways by a synthetic chondroitin sulfate-E tetrasaccharide promotes neurite outgrowth of dopaminergic neurons. J Neurochem 103:749-760.
44. Stein GS, Lian JB. 1993. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
45. Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T, Fujita T. 1999. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 140:2125-2133.
46. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R. 2003. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229-43235.
47. Takeuchi Y, Matsumoto T, Ogata E, Shishiba Y. 1990. Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process. Biochem J 266:15-24.
48. Tsuchida K, Shioi J, Yamada S, Boghosian G, Wu A, Cai H, Sugahara K, Robakis NK. 2001. Appican, the proteoglycan form of the amyloid precursor protein, contains chondroitin sulfate E in the repeating disaccharide region and 4-O-sulfated galactose in the linkage region. J Biol Chem 276:37155-37160.
49. Ueno A, Kitase Y, Moriyama K, Inoue H. 2001. MC3T3-E1-conditioned medium-induced mineralization by clonal rat dental pulp cells. Matrix Biol 20:347-355.
50. Ueoka C, Kaneda N, Okazaki I, Nadanaka S, Muramatsu T, Sugahara K. 2000. Neuronal cell adhesion, mediated by the heparin-binding neuroregulatory factor midkine, is specifically inhibited by chondroitin sulfate E. Structural and functional implications of the oversulfated chondroitin sulfate. J Biol Chem 275:37407-37413.
51. Wadhwa S, Bi Y, Ortiz AT, Embree MC, Kilts T, Iozzo R, Opperman LA, Young MF. 2007. Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice. Bone 40:861-866.
52. Wang Z, Clark CC, Brighton CT. 2006. Up-regulation of bone morphogenetic proteins in cultured murine bone cells with use of specific electric fields. J Bone Joint Surg Am 88:1053-1065.
53. Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN, Iredale JP. 2001. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 49:577-583.
54. Woessner JF Jr. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440-447.
55. Yoshida K, Miyauchi S, Kikuchi H, Tawada A, Tokuyasu K. 1989. Analysis of unsaturated disaccharides from glycosaminoglycuronan by high-performance liquid chromatography. Anal Biochem 177:327-332.
56. Zhao B,Katagiri T, Toyoda H, Takada T,Yanai T, Fukuda T, Chung UI, Koike T, Takaoka K, Kamijo R. 2006. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 281:23246-23253.
57. Zou P, Zou K, Muramatsu H, Ichihara-Tanaka K,Habuchi O, Ohtake S, Ikematsu S, Sakuma S, Muramatsu T. 2003. Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor. Glycobiology 13:35-42.